A Very Low Geno2pheno False Positive Rate Is Associated with Poor Viro-Immunological Response in Drug-Naïve Patients Starting a First-Line HAART-Reference-Cited by-同舟云学术

A Very Low Geno2pheno False Positive Rate Is Associated with Poor Viro-Immunological Response in Drug-Naïve Patients Starting a First-Line HAART

Published:2014-08-25 Issue:8 Volume:9 Page:e105853
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Armenia Daniele,Soulie Cathia,Di Carlo Domenico,Fabeni Lavinia,Gori Caterina,Forbici Federica,Svicher Valentina,Bertoli Ada,Sarmati Loredana,Giuliani Massimo,Latini Alessandra,Boumis Evangelo,Zaccarelli Mauro,Bellagamba Rita,Andreoni Massimo,Marcelin Anne-Geneviève,Calvez Vincent,Antinori Andrea,Ceccherini-Silberstein Francesca,Perno Carlo-Federico,Santoro Maria Mercedes

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Predictors of antiretroviral treatment failure in an urban HIV clinic;GK Robbins;J Acquir Immune Defic Syndr,2007

2. Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection;GK Robbins;N Engl J Med,2003

3. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions;GM Lucas;Ann Intern Med,1999

4. Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response;DM Moore;AIDS,2006

5. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy;GR Kaufmann;Clin Infect Dis,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term evolution of transmitted CXCR4-using HIV-1 under effective antiretroviral therapy;AIDS;2019-11-01

2. Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach;PLOS ONE;2019-03-11

3. Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen;Antiviral Therapy;2019

4. Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial;PLOS ONE;2017-11-21

5. Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses–an analysis of a prospective country-wide cohort;BMC Infectious Diseases;2017-01-06